The structural idiosyncrasies and promising biological effects of pyrone diterpenes render them exciting targets for total synthesis.^[@ref1]^ This modestly sized family of natural products,^[@ref2]^ so far only found in fungal strains, exhibits a wide range of bioactivities from immunosuppressive^[@cit2a],[@cit2c]^ to antihypertensive^[@ref3]^ yet differ in only subtle ways on the periphery of a decalin core. From a medicinal chemistry perspective, a convergent approach to rapidly assemble this core and install the side-chains in a divergent and modular fashion would be preferable. Prior approaches to this family ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A) have demonstrated the feasibility of accessing selected α-pyrone diterpenes in 21--27 steps via 5-methyl Wieland--Miescher ketone (prepared in 2 steps).^[@ref4]^ The main drawback of such approaches stems from a reliance on polar 2-electron disconnections that complicate stereoselective C--C bond formation and necessitate excessive functional group manipulations, protecting group interchanges, and unnecessary redox fluctuations.^[@ref5]^ Such a design makes it challenging to utilize one divergent route to access multiple family members. In stark contrast, single electron radical chemistry disconnections can unlock strategically powerful alternatives.^[@ref6]^ The 1-electron synthons generated through such an analysis of pyrone diterpenoids are easily traced back to diacid **1**. In the forward direction, key C--C bonds can be formed through decarboxylative Giese (C4--C20),^[@ref7]^ and alkenylation cross couplings (C12--C13).^[@ref8]^ A radical-based approach also allows multiple stereochemical challenges posed by this scaffold to be addressed in a simple way. As described in this Communication, sequential C--C bond forming radical cross-couplings (RCC) dramatically simplify access to this diterpenoid family as exemplified by improved syntheses of natural products **2**, **3**, and **5**. This short divergent path also enables the first total synthesis of **4** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B).

![(A) 1-electron vs 2-electron based retrosynthetic analyses for pyrone diterpenoid synthesis; (B) divergent access to natural products **2**-**5** through a modular approach.](ja-2018-04891j_0001){#fig1}

With the above considerations in mind, the minimally oxidized decalin **6** was chosen as an equivalent to **1** and the point of divergency to access natural products **2**--**5**. It was envisaged that such a construct could be easily accessed via a Snider-type radical polyene cyclization^[@ref9]^ of **7** followed by a Tsuji allylation.^[@ref10]^

[Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} outlines the divergent synthesis of **2**--**4,** in which the majority of C--C bonds are forged by radical-based methods. Commencing with polyene **7** (prepared in 2 steps, see [SI](#notes1){ref-type="notes"}), Mn-mediated radical polycyclization was initially employed. This powerful method, employed in dozens of natural product syntheses,^[@cit9c],[@ref11]^ historically utilizes an excess of Mn(III) salts (2--3 equiv) and varying levels of Cu(II)-based (0.1--1 equiv) salts, complicating reaction work up and making scale-up challenging and cumbersome. It was reasoned that this powerful redox cyclization could be rendered catalytic in both metals using electrochemistry. After extensive optimization (see [SI](#notes1){ref-type="notes"}), it was discovered that using a divided cell with substoichiometric amounts of Mn(II)-acetate (0.5 equiv) and catalytic Cu(II) 3,5-diisopropylsalicylate (0.02 equiv) resulted in a comparable isolated yield of **8** relative to classic stoichiometric conditions (42% vs 48%). Several points are notable in this improved Snider cyclization: (1) Mn(OAc)~2~ (ca. 7 cents/gram) is significantly less expensive than the Mn(III) salts \[Mn(OAc)~3~ costs ca. \$6/gram\] typically employed;^[@ref12]^ (2) the original conditions required rigorous solvent degassing and inert atmosphere while electrochemical conditions are conducted open to the air; (3) the use of Cu(sal)~2~ in this reaction is new and proved superior to other Cu-based salts presumably due to the enhanced chelation of the ligand; and (4) the significant reduction of metal-based waste also simplifies and accelerates the workup of these reactions (see inset graphic) on gram-scale. To our knowledge, this is the first nonstoichiometric implementation of this transformation.^[@ref13]^

![Syntheses of Subglutinols A (**2**), B (**3**), and Higginsianin A (**4**)\
See [Supporting Information](#notes1){ref-type="notes"} for reagents and conditions; Cu(sal)~2~ = copper(II) 3,5-diisopropylsalicylate, dba = dibenzylideneacetone, PHOX = phosphinooxazolines, TBHP = *tert*-butyl hydroperoxide, TES = triethylsilyl, THF = tetrahydrofuran, PIDA = (diacetoxyiodo)benzene, TEMPO = (2,2,6,6-tetramethylpiperidin-1-yl)oxyl, DCC = *N*,*N*′-dicyclohexylcarbodiimide, NHPI = *N*-hydroxyphthalimide, PPTS = pyridinium *p*-toluenesulfonate, DMP = Dess--Martin periodinane, TPAP = tetrapropylammonium perruthenate, NMO = 4-methylmorpholine N-oxide, DIC = *N*,*N*′-diisopropylcarbodiimide, TCNHPI = *N*-hydroxytetrachlorophthalimide, 2,2′-BiPy = 2,2′-bipyridine.](ja-2018-04891j_0002){#sch1}

The electrochemically assisted polycyclization solved a key bottleneck in the scale-up of **8**, which could then be subjected to a diastereoselective Tsuji-allylation using achiral H-PHOX^[@ref14]^ to access **6** (not isolated). In order to access the subglutinols (**2**--**3**), the reaction was quenched with LiAlH~4~ to deliver alcohol **9** as a single diastereomer (74% yield).^[@ref15]^ Subglutinols A (**2**) and B (**3**), two immunosuppressive members of the natural product family, are epimeric about C12.^[@cit2c]^ As described below, the strategic application of RCC enables late-stage diversification to access both natural products with complete stereocontrol. Sharpless's V-directed epoxidation^[@ref16]^ of **9** and *in situ* cyclization furnished a single THF diastereomer **10** as verified by X-ray crystallography (62% isolated yield). SeO~2~-mediated allylic oxidation followed by quenching with TESOTf provided allylic ether **11** in 51% yield (5:1 dr). Subsequent hydroboration/oxidation to form **12** set the stage for a key decarboxylative RCC with methyl acrylate (**A**).^[@ref7]^ Acid **12**, used directly from **11** without purification, was subjected to Giese-type RCC to access **13** (44% yield over 2 steps, 4:1 dr). This radical-based method, which essentially inverts the stereochemistry at C4, allows smooth access to a configuration was shown to be difficult to install in all prior approaches. With **13** in hand, the syntheses of **2** and **3** could be completed by installing the C-3 methylene, an isopropenyl group with the correct THF-stereochemistry at C12, and the hallmark pyrone moiety. Thus, conversion of **13** to the keto-aldehyde using PPTS and DMP followed by simple Takai--Lombardo olefination^[@ref17]^ afforded **14** (41% yield over 2 steps), completing the formal total synthesis of **2**.^[@cit4c]^ In the case of **3**, RCC proved crucial to invert C12 and install the isopropenyl unit with complete stereocontrol.^[@ref8]^ To that end, **13** was instead converted to an keto-acid using PPTS and TPAP/NMO.^[@ref18]^ Ni-catalyzed RCC with alkenyl zinc reagent **B** cleanly delivered **15**, after olefination, as a single diastereomer in 28% yield over 3 steps thereby completing the formal synthesis of **3**.^[@cit4c]^ RCC is a uniquely powerful tactic in this context as common radical precursors such as α-oxy halides would likely not be stable. This radical chemistry approach also represents a complete strategic departure for installing substituents and controlling the THF stereochemistry of the subglutinols at a late-stage (see [SI](#notes1){ref-type="notes"} for comparison to prior routes).

Higginsianin A (**4**), a relatively new member of this natural product family with promising anticancer bioactivity,^[@cit2e]^ differs slightly from **2** (opposite stereochemistry at C8) and the lessons learned from the subglutinol synthesis could be easily translated to allow access to synthetic **4** for the first time. Thus, subjection of crude **6** to [l]{.smallcaps}-selectride delivers the epimeric alcohol **16** (C8) as a single diastereomer (65% yield). Under Sharpless's V-directed epoxidation conditions an inconsequential mixture of diastereomers **17a** and **17b** at the THF-stereocenter (C12, ca. 1:1 dr) were obtained. The alcohol was converted to methyl ester using TPAP/NMO and *in situ* Steglich esterification. Allylic oxidation followed by quenching with TESOTf provided an allylic ether (52%, 5:1 dr at C3) that was subjected to hydroboration/oxidation and hydrolysis of methyl ester to form acid **18**. The lack of stereocontrol at C12 was irrelevant as a decarboxylative RCC on the mixture of epimers (**18**) with alkenyl zinc reagent **B** delivered a single diastereomer of **19** in 42% yield over two steps. Notably, the RCC proceeded uneventfully in the presence of the unprotected C20 primary alcohol. In a similar manner to the synthesis of **2** and **3**, the C4 stereocenter was also set using a radical coupling. Thus, sequential oxidation (DMP, followed by Pinnick oxidation) of **19** followed by a Giese RCC with **A** on crude **20** delivered **21** in 51% yield (4:1 dr). To complete the first total synthesis of **4**, a similar sequence of events was followed as with **2**/**3** involving olefination and pyrone installation (see [SI](#notes1){ref-type="notes"} for details).

Sesquicillin A (**5**),^[@cit2a]^ a natural product exhibiting a broad array of bioactivities, was also amenable to the same modular strategy as depicted in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. Triether **23**, available through a sequence analogous to that shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"} (see [SI](#notes1){ref-type="notes"}), was converted to acid **24** and directly subjected to Giese RCC with **A** to deliver homologated ester **25** in 40% yield (4:1 dr) over 2 steps. Removal of the TES-ethers and direct oxidation to keto-acid **26** set the stage for RCC with alkenyl zinc reagent **B**. Conversion to **27** as before completed the formal synthesis of sesquicillin A (**5**).^[@cit4a]^

![Synthesis of Sesquicillin A (**5**)\
See [Supporting Information](#notes1){ref-type="notes"} for reagents and conditions.](ja-2018-04891j_0003){#sch2}

It is notable that ca. 70% of the stereodefining C--C bond forming steps in these syntheses were achieved using radical chemistry. In several instances, two-electron chemistry simply failed or delivered the wrong stereochemistry (see [SI](#notes1){ref-type="notes"} for extensive listing). For example, multiple attempts to employ a classic alkyl-Suzuki coupling after hydroboration of intermediates such as **11**, **17**, and **23** only delivered the wrong diastereomer at C4 due to steric shielding by the C18 methyl group. In those cases, simple electrophiles such as bromobenzene or vinyl bromide (see [SI](#notes1){ref-type="notes"} for complete listing) were the only viable coupling partner rather than the necessary pyrone or any synthetic equivalent thereof. The C12 stereochemistry of **2** and **3** also posed a challenge for classic polar disconnections since it was set early (step 5) either as a mixture (for **4**) or as a single diastereomer (which would only allow access to **2**). Reliance on Wittig or related olefination methods would require custom routes for each C12 isomer in the case of **2** and **3** (see [SI](#notes1){ref-type="notes"} for discussion) or isomer separation in the case of **5**. By the strategic combination of one- and two-electron chemistry, four key stereocenters could be controlled through a simple relay wherein the C18 methyl group guided both C4 and C9, which consequently helped to set C8 and C12 stereocenters. Overall, the syntheses outlined above are a compelling demonstration of the power of both intramolecular^[@cit6b],[@ref19]^ and intermolecular radical-based chemistry to simplify access to a natural product family exhibiting a largely conserved core and differing peripheral substituents.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/jacs.8b04891](http://pubs.acs.org/doi/abs/10.1021/jacs.8b04891).Data for C~16~H~26~O~2~ ([CIF](http://pubs.acs.org/doi/suppl/10.1021/jacs.8b04891/suppl_file/ja8b04891_si_001.cif))Experimental procedures, analytical data (^1^H and ^13^C NMR, MS) for all new compounds as well as summaries of unsuccessful approaches ([PDF](http://pubs.acs.org/doi/suppl/10.1021/jacs.8b04891/suppl_file/ja8b04891_si_002.pdf))
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